EV/EBIT - Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd (SSE:688076) - Alpha Spread
J

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Watchlist Manager
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Watchlist
Price: 68.79 CNY 12.88% Market Closed
Market Cap: 15B CNY
Have any thoughts about
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

60.3
Current
59.9
Median
17.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
60.3
=
Enterprise Value
15B CNY
/
EBIT
248.7m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
49.7
2-Years Forward
EV/EBIT
32.8
3-Years Forward
EV/EBIT
23.7

See Also

Discover More